Subtopic Deep Dive
Prognostic Disclosure in Palliative Care
Research Guide
What is Prognostic Disclosure in Palliative Care?
Prognostic disclosure in palliative care is the process of communicating survival estimates and disease trajectory to patients and families nearing end-of-life.
This subfield analyzes physician practices, patient preferences, and psychological outcomes of truth-telling in advanced cancer. Key studies show physicians provide frank estimates only 37% of the time even when requested (Lamont and Christakis, 2001, 538 citations). Systematic reviews identify preferences for content, style, and timing of prognostic information (Parker et al., 2007, 521 citations). Over 20 papers from 1999-2018 address disclosure patterns and impacts.
Why It Matters
Prognostic disclosure enables informed advance care planning and aligns treatments with patient values, as patients often overestimate chemotherapy cure rates (Weeks et al., 2012, 1134 citations). Poor disclosure links to higher depression and adjustment disorders in terminally ill patients (Akechi et al., 2004, 531 citations). Evidence-based recommendations improve communication, reducing futile care and enhancing quality of life (Maltoni et al., 2005, 673 citations). Integration with oncology supports timely palliative shifts (Kaasa et al., 2018, 780 citations).
Key Research Challenges
Low Frank Disclosure Rates
Physicians disclose accurate survival estimates only 37% of the time despite patient requests, often using overestimates or no estimates (Lamont and Christakis, 2001). This stems from fear of distress and cultural norms. Interventions to boost truth-telling remain limited.
Variable Patient Preferences
Patients and caregivers differ on desired timing, style, and detail of prognostic information across cultures (Parker et al., 2007). Systematic reviews highlight inconsistent preferences. Tailoring disclosure requires validated tools.
Psychological Impact Assessment
Prognostic talks associate with depression and PTSD in advanced cancer, but predictive factors need clarification (Akechi et al., 2004). Measuring coping responses post-disclosure lacks standardized metrics. Longitudinal studies are scarce.
Essential Papers
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
M.H.J. van den Beuken-van Everdingen, Laura Hochstenbach, Elbert A.J. Joosten et al. · 2016 · Journal of Pain and Symptom Management · 1.6K citations
Defining Advance Care Planning for Adults: A Consensus Definition From a Multidisciplinary Delphi Panel
Rebecca L. Sudore, Hillary D. Lum, John J. You et al. · 2017 · Journal of Pain and Symptom Management · 1.6K citations
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
Jane C. Weeks, Paul J. Catalano, Angel M. Cronin et al. · 2012 · New England Journal of Medicine · 1.1K citations
Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions...
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon Håvard Loge, Matti Aapro et al. · 2018 · The Lancet Oncology · 780 citations
Full integration of oncology and palliative care relies on the specific knowledge and skills of two modes of care: the tumour-directed approach, the main focus of which is on treating the disease; ...
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
Marco Maltoni, Augusto Caraceni, Cinzia Brunelli et al. · 2005 · Journal of Clinical Oncology · 673 citations
Purpose To offer evidence-based clinical recommendations concerning prognosis in advanced cancer patients. Methods A Working Group of the Research Network of the European Association for Palliative...
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) [RETIRED]
Robert G. Miller, J. Rosenberg, Deborah Gelinas et al. · 1999 · Neurology · 574 citations
Mission statement
Prognostic Disclosure to Patients with Cancer near the End of Life
Elizabeth B. Lamont, Nicholas A. Christakis · 2001 · Annals of Internal Medicine · 538 citations
Physicians reported that even if patients with cancer requested survival estimates, they would provide a frank estimate only 37% of the time and would provide no estimate, a conscious overestimate,...
Reading Guide
Foundational Papers
Start with Lamont and Christakis (2001) for baseline physician disclosure patterns (37% frank estimates), then Maltoni et al. (2005) for prognostic factor guidelines, and Weeks et al. (2012) for patient expectation mismatches.
Recent Advances
Study Parker et al. (2007) for systematic preferences review and Kaasa et al. (2018) for oncology-palliative integration emphasizing communication.
Core Methods
Core techniques include physician surveys (Lamont 2001), Delphi panels for recommendations (Maltoni 2005), and systematic reviews of preferences (Parker 2007). Patient interviews assess chemotherapy expectations (Weeks 2012).
How PapersFlow Helps You Research Prognostic Disclosure in Palliative Care
Discover & Search
Research Agent uses searchPapers with query 'prognostic disclosure palliative care' to retrieve Lamont and Christakis (2001), then citationGraph reveals 538 citing works including Parker et al. (2007), and findSimilarPapers expands to cultural adaptations.
Analyze & Verify
Analysis Agent applies readPaperContent on Lamont and Christakis (2001) to extract 37% frank disclosure statistic, verifies with CoVe against Weeks et al. (2012), and runPythonAnalysis performs meta-analysis on prevalence data from van den Beuken-van Everdingen et al. (2016) using GRADE for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in cultural prognostic preferences via contradiction flagging across Parker et al. (2007) and Akechi et al. (2004), then Writing Agent uses latexEditText for disclosure framework drafts, latexSyncCitations for 10+ references, and latexCompile for publication-ready review.
Use Cases
"Extract survival estimate disclosure rates from palliative care studies and plot trends"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on citation data from Lamont 2001 and Maltoni 2005) → trend graph showing 37% frank disclosure baseline.
"Draft LaTeX review on prognostic disclosure preferences with citations"
Synthesis Agent → gap detection on Parker 2007 → Writing Agent → latexEditText (structure sections) → latexSyncCitations (add Weeks 2012, Akechi 2004) → latexCompile → PDF with integrated bibliography.
"Find code for prognostic modeling in end-of-life papers"
Research Agent → searchPapers 'prognostic factors advanced cancer code' → paperExtractUrls (from Maltoni 2005 cites) → paperFindGithubRepo → githubRepoInspect → R scripts for survival analysis from EAPC recommendations.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ hits on 'prognostic disclosure cancer'), citationGraph clustering, GRADE grading yielding structured report on disclosure rates from Lamont (2001) to Kaasa (2018). DeepScan applies 7-step analysis with CoVe checkpoints to verify psychological impacts in Akechi (2004). Theorizer generates truth-telling frameworks from Parker (2007) preferences and Weeks (2012) expectations.
Frequently Asked Questions
What is prognostic disclosure in palliative care?
It involves physicians communicating accurate survival estimates to advanced cancer patients and families. Studies show frank disclosure occurs only 37% of the time upon request (Lamont and Christakis, 2001).
What methods assess disclosure effectiveness?
Systematic reviews evaluate patient/caregiver preferences for information content, style, and timing (Parker et al., 2007). Surveys measure physician practices and patient understanding (Weeks et al., 2012).
What are key papers on this topic?
Lamont and Christakis (2001, 538 citations) quantify low frank disclosure rates. Maltoni et al. (2005, 673 citations) provide evidence-based prognostic factor recommendations. Parker et al. (2007, 521 citations) review communication preferences.
What open problems exist?
Cultural adaptations for disclosure preferences lack global trials. Predictive models for post-disclosure distress need validation beyond Akechi et al. (2004). Standardized training for physicians remains underdeveloped.
Research Palliative Care and End-of-Life Issues with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Prognostic Disclosure in Palliative Care with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers